1Eggimann P,Chiolero R,Chassot PG et al.Systemic and hemodynamic effects of recombinant tumor necrosis factor-alpha in isolation perfusion of the limbs[].Chest.1995
2Sakurai A,Hara S,Okano N et al.Regulatory role of metallothioneine in NF-kappa B activation[].FEBS Letters.1999
3Liddil JD,Dorr RT.Schedule dependent toxicity of tumor necrosis factor in rodents[].Cancer Drug Delivery.1987
4Van Ostade X,Tavernier J,Prange T et al.Localization of the active site of human tumor necrosis factor(hTNF) by mutational analysis[].EMBO Journal.1991
7Wallach D,Boldin M,Varfolomeev E et al.Cell death induction by receptors of the TNF family: towards a molecular understanding[].FEBS Letters.1997
8Hsu H,Shu HB,Pan MG et al.TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways[].Cell.1996
9Fuortes M,Melchior N,Han H et al.Role of the tyrosinekinase pyk2 in the integrin-dependent activation of human neutrophils by TNF[].The Journal of Clinical Investigation.1999
10Grell M,Douni E,Wajiant H et al.The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor[].Cell.1995
